1275
GUT VIROME ASSOCIATED WITH IMPROVED ATHEROGENIC LIPOPROTEIN AND LIVER STEATOSIS AFTER FECAL MICROBIOTA TRANSPLANTATION IN OBESE SUBJECTS WITH TYPE 2 DIABETES
Date
May 21, 2024
Tracks
Related Products
FAECAL MICROBIOTA TRANSPLANTATION FOR POST-ACUTE COVID-19 SYNDROME: AN OPEN-LABEL PILOT TRIAL (FMT-PACS STUDY)
BACKGROUND: Post-acute COVID-19 syndrome (PACS) affects sleep and neuropsychiatric functions but treatment is limited. We aimed to assess the effects of faecal microbiota transplantation (FMT) in alleviating post-COVID insomnia and anxiety…
EFFECTS OF GUT MICROBIOME MODULATION ON CLINICAL OUTCOMES AND GUT DYSBIOSIS AMONG ELDERLY AND DIABETES PATIENTS AFTER COVID-19 VACCINATION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
BACKGROUND: Emerging evidence suggest that gut microbiota influence human health such as digestive functions and risk of sepsis…
EFFECT OF GUT MICROBIOME MODULATION IN ENHANCING IMMUNOGENICITY AFTER SARS-COV-2 VACCINATION IN ELDERLY AND DIABETES PATIENTS (IMPACT STUDY)
INTRODUCTION: Gut dysbiosis has been associated with suboptimal antibody response after vaccination. We aimed to evaluate the oral microbiome immunity formula (SIM01) in enhancing immunogenicity after SARS-CoV-2 vaccination in vulnerable populations…
REGIONAL MICROBIOTA MISMATCHES FROM FECAL MICROBIOTA TRANSPLANTS DRIVE PERSISTENT, OFF-TARGET CONSEQUENCES TO THE HOST
Fecal microbiota transplant (FMT) is a promising, novel intervention to promote restitution and repair of colonic dysbiosis…